Track the 중앙백신 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 중앙백신 has recorded 19 reports. Market capitalisation: €85.3bn. The latest transaction was disclosed on 29 April 2026 (Purchase). Among the most active insiders: 중앙백신. The full history is free.
19
Insider Decl.
n/a
Thresholds
€250,922
6 ops.
Buy Volume
n/a
5 ops.
Sell Volume
32Σ signal
Buys €250,922n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,411 of 28,024 companies
67.2
score / 100
Value
69
Quality
65
FCF yld2.2%
Earn yld7.2%
EV/EBITDA7.0x
ROE3.8%
Gross mgn49%
Net mgn13%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Central Vaccine is a company operating in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and distribution of vaccines.